Latest Breaking News On - Haim neerman - Page 1 : vimarsana.com

Variantyx Raises $36M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

Variantyx Raises Additional Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Variantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint

Framingham genetic testing firm lands $41.5M in funding

Variantyx, a Framingham firm specializing in advanced genomic testing for rare genetic disorders, reproductive health, and precision oncology, has secured $41.5 million in additional funding to advance its rapidly growing global precision oncology business.

Variantyx Secures $41.5M in Series C-2 Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding

/PRNewswire/ Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive.

Variantyx nabs $41.1M for tech-backed genomic analysis

The company plans to use the funds to focus on the oncology space.

Robert Bosch Venture Capital Invests Approx. $26M in Variantyx

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!